# Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients

> **NCT01055236** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 80 (actual)

## Conditions studied

- Pruritus
- Nausea
- Vomiting

## Interventions

- **DRUG:** hydroxyzine

## Key facts

- **NCT ID:** NCT01055236
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2010-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055236, "Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01055236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*